Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...